For example, high expression of hexokinase 2 (HK2) in tumor cells can suppress transcription of the gene encoding IFN-γ, thereby contributing to immune response evasion.271 This concept of “oncometabolites” has ushered in a new era for cancer treatment. The gene discussed is HK2; the disease is cancer.